Role of dietary lignans in the reduction of breast cancer risk.

Functional Foods Forum, University of Turku, Turku, Finland.
Molecular Nutrition & Food Research (Impact Factor: 4.31). 08/2007; 51(7):857-66. DOI: 10.1002/mnfr.200600240
Source: PubMed

ABSTRACT Lignans are a large group of fiber-associated phenolic compounds widely distributed in edible plants. Some of the ingested plant lignans are converted by intestinal microbiota to enterolignans, enterodiol (END) and enterolactone (ENL), the latter of which has been thought to be the major biologically active lignan, and suggested to be associated with low risk of breast cancer. In line with this, administration of plant lignans which are further metabolized to ENL, or ENL as such, have been shown to inhibit or delay the growth of experimental mammary cancer. The mechanism of anticarcinogenic action of ENL is not yet fully understood, but there is intriguing evidence for ENL as a modulator of estrogen signaling. These findings have generated interest in the use of lignans as components of breast cancer risk reducing functional foods. Identification of target groups, who would benefit most, is of pivotal importance. Therefore, further identification and validation of relevant biomarkers, which can be used as indicators of lignan or ENL action and breast cancer risk reduction at different stages of the disease, are of importance.

1 Bookmark
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Flaxseed is the richest plant source of the lignan secoisolariciresinol diglucoside (SDG). In flaxseed, SDG exists in an oligomeric structure with 3-hydroxy-3-methyl glutaric acid (HMGA) forming a phenolic complex together with p-coumaric acid and ferulic acid glucosides and herbacetin diglucoside (HDG). Epidemiological and animal studies indicate protective effects of flaxseed and SDG towards hormone-dependent cancers and cardiovascular diseases, and reducing effect toward cholesterol levels in blood. Knowledge about the structural features and properties of the phenolic complex are required to further understand bioavailability, bioconversion and bioactivity of flaxseed lignans in humans and animals, the biosynthesis in flaxseed, as well as if it may affect technology and quality of food products containing flaxseed or the phenolic complex. A new fast and simple high-performance liquid chromatographic (HPLC) method was developed for analysing secoisolariciresinol diglucoside (SDG), p-coumaric acid glucoside and ferulic acid glucoside, based on direct hydrolysis of defatted flaxseed flour using alkali. Variations in SDG, p-coumaric acid glucoside and ferulic acid glucoside content were reported in flaxseed samples and bread products containing flaxseed. The composition and properties of flaxseed phenolic complex were studied by reversed-phase liquid chromatography and gel filtration fractionation. Results indicate that the phenolic glucosides exist in oligomers with variable molecular sizes. A complicated linkage pattern and/or possibly interactions with other components may contribute to the observed complexity. SDG and the phenolic complex showed similar hydrogen-donating abilities to ferulic acid but higher than α-tocopherol in the DPPH inhibition metod, suggesting that SDG was the only active antioxidant in the phenolic complex. Contradicting results were obtained on the effect of SDG on levels of Vitamin E and cholesterol in two rat studies.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Abstract This study aims at investigating the effect of an experimental period of intake of whole grain foods rich in lignans as part of an habitual diet on the plasma and urinary excretion of enterolignans, the biomarkers of lipid metabolism and the immunological and antioxidant status in a group of postmenopausal women with moderate serum cholesterol. A randomized double-blind crossover study was completed on 13 subjects in 12-weeks after protocol approval of an ethical committee. The subjects consumed whole grain foods high in lignans (30 g/d of breakfast cereals or biscuits, etc., 80 g/d of whole grain pasta) or refined grain foods for 4 weeks, separated by a 2-weeks wash-out period. A modest hypocholesterolemic effect (p < 0.05) of the whole grain diet was observed and the intake of whole grain products rich in lignans was also associated with an increase in urinary enterodiol excretion (p < 0.05).
    International Journal of Food Sciences and Nutrition 03/2014; · 1.26 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Multidrug resistance protein 1 (MRP1/ABCC1) is one of the drug efflux pumps mediating multidrug resistance in several cancer types. Efficient nontoxic inhibitors of MRP1-mediated transport are sought to potentially sensitise cancer cells to anticancer drugs. This study examined the potency of a series of plant lignans and norlignans of various structures to inhibit MRP1-mediated transport from human erythrocytes. The occurrence of MRP1 in the human erythrocyte membrane makes this cell a useful model in searching for efficient MRP1inhibitors. The inhibition of 2',7'-bis-(carboxypropyl)-5(6)-carboxyfluorescein (BCPCF) transport from human erythrocytes was measured fluorymetrically. In order to study possible membrane-perturbing effects of lignans and norlignans, the potency of these compounds to induce haemolysis, erythrocyte shape change, and phosphatidylserine (PS) exposure in the external layer of the erythrocyte membrane was examined. Nine compounds (six norlignans and three lignans) of the fourteen that were tested inhibited BCPCF transport from human erythrocytes. The most efficient inhibitor, the norlignan coded L1, had IC(50)=50 μM. Structure-activity relationship analysis showed that the strongest inhibitors were found among lignans and norlignans bearing a carbonyl function at position C-9. The highly oxidised structures and the presence of an ionisable group such as the carboxylic acid function enhance activity. All compounds that significantly decreased BCPCF transport were non-haemolytic, did not cause PS exposure and did not have any effect on erythrocyte shapes up to 200 μM. Lignans and norlignans can inhibit MRP1-mediated transport from human erythrocytes and should be further investigated as possible agents reversing multidrug resistance.
    Anticancer research 11/2010; 30(11):4423-8. · 1.71 Impact Factor


Available from
May 19, 2014